We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Diabetic Charcot Foot Surgery Shows High Success Rate

By HospiMedica International staff writers
Posted on 26 Dec 2017
Nearly 80% of diabetic patients with severe Charcot foot inflammation are able to walk normally again following surgery, according to a new study.

Researchers at Loyola University Health System (Chicago, IL, USA) conducted a retrospective study of 214 patients who underwent surgical reconstruction of deformities associated with mid-tarsal Charcot foot arthropathy over a 12-year period. More...
Surgery included resection of infection when present, Achilles tendon lengthening, correction of the structural deformity by wedge resection, and immobilization with a three-level static circular external fixator. Clinical outcomes were based on limb salvage, resolution of infection, and the functional metric of the ability to walk with commercially available therapeutic footwear.

The results revealed that 173 of the 223 feet operated on had good or excellent outcomes, defined as being free of ulcers and infections and able to walk outside using off-the-shelf therapeutic footwear and custom foot braces. Success rates varied according to the type of foot deformity; patients with a valgus deformity pattern had an 87% success rate; patients with a dislocation pattern deformity had a 70.3% success rate; and those with a varus deformity pattern had a 56.3% success rate. Seven patients died of unrelated causes within a year of surgery, and 15 underwent partial- or whole-foot amputations. The study was published on November 27, 2017, in Foot and Ankle International.

“Operative correction of the acquired deformity of Charcot foot arthropathy was performed with a goal of improving quality of life. The clinical outcomes achieved in this retrospective case series appear to support the modern paradigm of operative correction of deformity in this complex patient population,” concluded lead author orthopedic surgeon Michael Pinzur, MD. “This realistic appreciation of outcome expectations should both be helpful in counseling patients on the risk-benefit ratio associated with surgery, and provide a benchmark to measure newer strategies of treatment.”

First described in 1883, diabetic Charcot foot is characterized by varying degrees of bone and joint disorganization secondary to underlying neuropathy, trauma, and perturbations of bone metabolism. The bones are weakened enough to fracture, and with continued walking, the foot eventually deforms. The hallmark deformity is midfoot collapse, described as a “rocker-bottom” foot, although it can appear in other joints and with other presentations.

Related Links:
Loyola University Health System


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.